Trial Outcomes & Findings for Understanding the Role of Gut Microbiota in Hyperphagia in Prader-Willi Syndrome (NCT NCT05541003)

NCT ID: NCT05541003

Last Updated: 2024-07-16

Results Overview

Alpha Diversity measured by Shannon index. The Shannon Index is a measure of diversity of microbial species that takes into account both abundance (the number of species present) and evenness (how close the numbers for each species are). The Shannon index can be calculated using the following equation: H= -∑(i=1)\^s pi ln(pi). A value of zero for H indicates that a community has only one species. The higher the value of H, the higher the diversity of species in a particular community.

Recruitment status

COMPLETED

Study phase

PHASE2

Target enrollment

12 participants

Primary outcome timeframe

Weeks 0

Results posted on

2024-07-16

Participant Flow

Recruitment time period was from 11/1/2022 to 3/1/2023. Recruitment occurred from Robert Wood Johnson medical clinics.

No patients were excluded from the study before assignment to arms or groups.

Participant milestones

Participant milestones
Measure
Experimental Arm
All participants will receive NBT-NM108 prepared as muffin (each contains 30 g of the product) for 4 weeks. The dosage will be 2 muffins a day. This dosage of NBT-NM108 will provide 24 g/day of dietary fibers. NBT-NM108: All patients will consume NBT-NM108 in the form of 2 muffins daily.
Overall Study
STARTED
12
Overall Study
COMPLETED
10
Overall Study
NOT COMPLETED
2

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Fiber Intervention
n=12 Participants
All patients were given 48 grams of NBT-NM108 dietary fiber in the form of 2 muffins per day
Age, Continuous
28 Years
STANDARD_DEVIATION 9 • n=12 Participants
Sex: Female, Male
Female
9 Participants
n=12 Participants
Sex: Female, Male
Male
3 Participants
n=12 Participants
Region of Enrollment
United States
12 Participants
n=12 Participants
Weight
107.01 kilogram
STANDARD_DEVIATION 21.33 • n=12 Participants
BMI
38.58 kg/m^2
STANDARD_DEVIATION 7.82 • n=12 Participants
Systolic Blood Pressure
135 mmHg
STANDARD_DEVIATION 13.64 • n=12 Participants
Diastolic Blood Pressure
88.91 mmHg
STANDARD_DEVIATION 9.63 • n=12 Participants
Heart Rate
81.55 Beats per minute
STANDARD_DEVIATION 15.92 • n=12 Participants

PRIMARY outcome

Timeframe: Weeks 0

Population: Alpha Diversity measured by Shannon index. The Shannon Index is a measure of diversity of microbial species that takes into account both abundance (the number of species present) and evenness (how close the numbers for each species are). The Shannon index can be calculated using the following equation: H= -∑(i=1)\^s pi ln(pi). A value of zero for H indicates that a community has only one species. The higher the value of H, the higher the diversity of species in a particular community. No units.

Alpha Diversity measured by Shannon index. The Shannon Index is a measure of diversity of microbial species that takes into account both abundance (the number of species present) and evenness (how close the numbers for each species are). The Shannon index can be calculated using the following equation: H= -∑(i=1)\^s pi ln(pi). A value of zero for H indicates that a community has only one species. The higher the value of H, the higher the diversity of species in a particular community.

Outcome measures

Outcome measures
Measure
Microbiome Structure
n=10 Participants
In this pilot study, we collected 20 fecal samples from 10 subjects before and after the dietary intervention. We extracted the metagenomic DNA from the fecal samples and applied 16S rRNA gene amplicon sequencing to understand the impact of NBT-NM108 on the gut microbiome. We obtained \~980,000 high-quality sequencing reads from 20 samples and have identified 757 amplicon sequence variants (ASVs) from these samples. For subsequent analysis the number of sequencing reads per sample was normalized to 34,000 per sample. Alpha and beta diversity were analyzed to assess changes of the overall gut microbiota structure. Alpha diversity describes the overall gut microbiota structure within a single sample.
Microbiome Analysis: Alpha Diversity
4.89 Shannon index
Standard Deviation 0.46

PRIMARY outcome

Timeframe: Week 4

Population: For alpha diversity, Shannon index was used.

Alpha diversity measured by Shannon index. "The Shannon Index is a measure of diversity of microbial species that takes into account both abundance (the number of species present) and evenness (how close the numbers for each species are). The Shannon index can be calculated using the following equation: H= -∑(i=1)\^s pi ln(pi). A value of zero for H indicates that a community has only one species. The higher the value of H, the higher the diversity of species in a particular community.

Outcome measures

Outcome measures
Measure
Microbiome Structure
n=10 Participants
In this pilot study, we collected 20 fecal samples from 10 subjects before and after the dietary intervention. We extracted the metagenomic DNA from the fecal samples and applied 16S rRNA gene amplicon sequencing to understand the impact of NBT-NM108 on the gut microbiome. We obtained \~980,000 high-quality sequencing reads from 20 samples and have identified 757 amplicon sequence variants (ASVs) from these samples. For subsequent analysis the number of sequencing reads per sample was normalized to 34,000 per sample. Alpha and beta diversity were analyzed to assess changes of the overall gut microbiota structure. Alpha diversity describes the overall gut microbiota structure within a single sample.
Microbiome Analysis: Alpha Diversity
4.73 Shannon index
Standard Deviation 0.41

PRIMARY outcome

Timeframe: Week 0

Population: For beta diversity, Bray-Curtis dissimilarity index was computed for each sample. Bray-Curtis dissimilarity index is represented as Median (Inter-Quartile Range).

The Bray-Curtis distance was used to compute the distances for each sample. Bray-Curtis distance uses species abundance information and membership to calculate the distance between samples. The Bray-Curtis dissimilarity index for a sample ranges between 0 and 1. A value of 0 indicates no difference between the samples, while a value of 1 represents the maximum distance between them

Outcome measures

Outcome measures
Measure
Microbiome Structure
n=10 Participants
In this pilot study, we collected 20 fecal samples from 10 subjects before and after the dietary intervention. We extracted the metagenomic DNA from the fecal samples and applied 16S rRNA gene amplicon sequencing to understand the impact of NBT-NM108 on the gut microbiome. We obtained \~980,000 high-quality sequencing reads from 20 samples and have identified 757 amplicon sequence variants (ASVs) from these samples. For subsequent analysis the number of sequencing reads per sample was normalized to 34,000 per sample. Alpha and beta diversity were analyzed to assess changes of the overall gut microbiota structure. Alpha diversity describes the overall gut microbiota structure within a single sample.
Microbiome Analysis: Beta Diversity
0.76 Bray-Curtis distance
Interval 0.65 to 0.81

PRIMARY outcome

Timeframe: Week 4

Population: For beta diversity, Bray-Curtis dissimilarity index was computed for each sample.

The Bray-Curtis distance was used to compute the distances for each sample. Bray-Curtis distance uses species abundance information and membership to calculate the distance between samples. The Bray-Curtis dissimilarity index for a sample ranges between 0 and 1. A value of 0 indicates no difference between the samples, while a value of 1 represents the maximum distance between them

Outcome measures

Outcome measures
Measure
Microbiome Structure
n=10 Participants
In this pilot study, we collected 20 fecal samples from 10 subjects before and after the dietary intervention. We extracted the metagenomic DNA from the fecal samples and applied 16S rRNA gene amplicon sequencing to understand the impact of NBT-NM108 on the gut microbiome. We obtained \~980,000 high-quality sequencing reads from 20 samples and have identified 757 amplicon sequence variants (ASVs) from these samples. For subsequent analysis the number of sequencing reads per sample was normalized to 34,000 per sample. Alpha and beta diversity were analyzed to assess changes of the overall gut microbiota structure. Alpha diversity describes the overall gut microbiota structure within a single sample.
Microbiome Analysis: Beta Diversity
0.73 Bray-Curtis distance
Interval 0.64 to 0.79

SECONDARY outcome

Timeframe: Week 4

Weight in kg

Outcome measures

Outcome measures
Measure
Microbiome Structure
n=10 Participants
In this pilot study, we collected 20 fecal samples from 10 subjects before and after the dietary intervention. We extracted the metagenomic DNA from the fecal samples and applied 16S rRNA gene amplicon sequencing to understand the impact of NBT-NM108 on the gut microbiome. We obtained \~980,000 high-quality sequencing reads from 20 samples and have identified 757 amplicon sequence variants (ASVs) from these samples. For subsequent analysis the number of sequencing reads per sample was normalized to 34,000 per sample. Alpha and beta diversity were analyzed to assess changes of the overall gut microbiota structure. Alpha diversity describes the overall gut microbiota structure within a single sample.
Weight
107 Kilogram
Standard Deviation 22

SECONDARY outcome

Timeframe: Week 0

Population: Looking at iAUC for early and late response phases after meal.

Early response to meal post-intervention is 0-30min. Late response phase to meal post-intervention is 60-180min.

Outcome measures

Outcome measures
Measure
Microbiome Structure
n=10 Participants
In this pilot study, we collected 20 fecal samples from 10 subjects before and after the dietary intervention. We extracted the metagenomic DNA from the fecal samples and applied 16S rRNA gene amplicon sequencing to understand the impact of NBT-NM108 on the gut microbiome. We obtained \~980,000 high-quality sequencing reads from 20 samples and have identified 757 amplicon sequence variants (ASVs) from these samples. For subsequent analysis the number of sequencing reads per sample was normalized to 34,000 per sample. Alpha and beta diversity were analyzed to assess changes of the overall gut microbiota structure. Alpha diversity describes the overall gut microbiota structure within a single sample.
Acyl-Ghrelin Level
Early Response
13.47 pg*min/mL
Standard Deviation 22.54
Acyl-Ghrelin Level
Late Response
187 pg*min/mL
Standard Deviation 191

SECONDARY outcome

Timeframe: Week 4

Population: Looking at iAUC for early and late response phases after meal.

Early response to meal post-intervention is 0-30min. Late response phase to meal post-intervention is 60-180min.

Outcome measures

Outcome measures
Measure
Microbiome Structure
n=10 Participants
In this pilot study, we collected 20 fecal samples from 10 subjects before and after the dietary intervention. We extracted the metagenomic DNA from the fecal samples and applied 16S rRNA gene amplicon sequencing to understand the impact of NBT-NM108 on the gut microbiome. We obtained \~980,000 high-quality sequencing reads from 20 samples and have identified 757 amplicon sequence variants (ASVs) from these samples. For subsequent analysis the number of sequencing reads per sample was normalized to 34,000 per sample. Alpha and beta diversity were analyzed to assess changes of the overall gut microbiota structure. Alpha diversity describes the overall gut microbiota structure within a single sample.
Acyl-Ghrelin Level
Early Response
12.5 pg*min/mL
Standard Deviation 17.6
Acyl-Ghrelin Level
Late Response
278 pg*min/mL
Standard Deviation 605

SECONDARY outcome

Timeframe: Week 0

Population: Looking at iAUC for early and late response phases after meal.

Early response to meal post-intervention is 0-30min. Late response phase to meal post-intervention is 60-180min.

Outcome measures

Outcome measures
Measure
Microbiome Structure
n=10 Participants
In this pilot study, we collected 20 fecal samples from 10 subjects before and after the dietary intervention. We extracted the metagenomic DNA from the fecal samples and applied 16S rRNA gene amplicon sequencing to understand the impact of NBT-NM108 on the gut microbiome. We obtained \~980,000 high-quality sequencing reads from 20 samples and have identified 757 amplicon sequence variants (ASVs) from these samples. For subsequent analysis the number of sequencing reads per sample was normalized to 34,000 per sample. Alpha and beta diversity were analyzed to assess changes of the overall gut microbiota structure. Alpha diversity describes the overall gut microbiota structure within a single sample.
Peptide YY (PYY)
early phase (0-30min)
0.23 pg*min/mL
Standard Deviation 0.37
Peptide YY (PYY)
late phase response (60-180min)
4.01 pg*min/mL
Standard Deviation 4.22

SECONDARY outcome

Timeframe: Week 4

Population: Looking at iAUC for early and late response phase after meal.

Early response to meal post-intervention is 0-30min. Late response phase to meal post-intervention is 60-180min.

Outcome measures

Outcome measures
Measure
Microbiome Structure
n=10 Participants
In this pilot study, we collected 20 fecal samples from 10 subjects before and after the dietary intervention. We extracted the metagenomic DNA from the fecal samples and applied 16S rRNA gene amplicon sequencing to understand the impact of NBT-NM108 on the gut microbiome. We obtained \~980,000 high-quality sequencing reads from 20 samples and have identified 757 amplicon sequence variants (ASVs) from these samples. For subsequent analysis the number of sequencing reads per sample was normalized to 34,000 per sample. Alpha and beta diversity were analyzed to assess changes of the overall gut microbiota structure. Alpha diversity describes the overall gut microbiota structure within a single sample.
Peptide YY (PYY)
early phase (0-30min)
0.614 pg*min/mL
Standard Deviation 1.43
Peptide YY (PYY)
late phase response (60-180min)
11.1 pg*min/mL
Standard Deviation 14.1

SECONDARY outcome

Timeframe: Week 0

Population: Looking at iAUC for early and late response phase after meal.

GLP1 levels were measured in patients before fiber intervention. Early response to meal post-intervention is 0-30min. Late response phase to meal post-intervention is 60-180min.

Outcome measures

Outcome measures
Measure
Microbiome Structure
n=10 Participants
In this pilot study, we collected 20 fecal samples from 10 subjects before and after the dietary intervention. We extracted the metagenomic DNA from the fecal samples and applied 16S rRNA gene amplicon sequencing to understand the impact of NBT-NM108 on the gut microbiome. We obtained \~980,000 high-quality sequencing reads from 20 samples and have identified 757 amplicon sequence variants (ASVs) from these samples. For subsequent analysis the number of sequencing reads per sample was normalized to 34,000 per sample. Alpha and beta diversity were analyzed to assess changes of the overall gut microbiota structure. Alpha diversity describes the overall gut microbiota structure within a single sample.
Glucagon Like Peptide 1 (GLP1)
early phase (0-30min)
10.6 pg*min/ml
Standard Deviation 15.8
Glucagon Like Peptide 1 (GLP1)
late phase response (60-180min)
115 pg*min/ml
Standard Deviation 184

SECONDARY outcome

Timeframe: Week 4

Population: Looking at iAUC for early and late response phase after meal.

GLP1 levels were measured in patients after fiber intervention. Early response to meal post-intervention is 0-30min. Late response phase to meal post-intervention is 60-180min.

Outcome measures

Outcome measures
Measure
Microbiome Structure
n=10 Participants
In this pilot study, we collected 20 fecal samples from 10 subjects before and after the dietary intervention. We extracted the metagenomic DNA from the fecal samples and applied 16S rRNA gene amplicon sequencing to understand the impact of NBT-NM108 on the gut microbiome. We obtained \~980,000 high-quality sequencing reads from 20 samples and have identified 757 amplicon sequence variants (ASVs) from these samples. For subsequent analysis the number of sequencing reads per sample was normalized to 34,000 per sample. Alpha and beta diversity were analyzed to assess changes of the overall gut microbiota structure. Alpha diversity describes the overall gut microbiota structure within a single sample.
Glucagon Like Peptide 1 (GLP1)
early phase (0-30min)
4.44 pg*min/ml
Standard Deviation 6.85
Glucagon Like Peptide 1 (GLP1)
late phase response (60-180min)
79.6 pg*min/ml
Standard Deviation 55.7

SECONDARY outcome

Timeframe: Week 0

Population: Looking at iAUC for early and late response phase after meal.

Insulin levels were measured in patients before fiber intervention. Early response to meal post-intervention is 0-30min. Late response phase to meal post-intervention is 60-180min.

Outcome measures

Outcome measures
Measure
Microbiome Structure
n=10 Participants
In this pilot study, we collected 20 fecal samples from 10 subjects before and after the dietary intervention. We extracted the metagenomic DNA from the fecal samples and applied 16S rRNA gene amplicon sequencing to understand the impact of NBT-NM108 on the gut microbiome. We obtained \~980,000 high-quality sequencing reads from 20 samples and have identified 757 amplicon sequence variants (ASVs) from these samples. For subsequent analysis the number of sequencing reads per sample was normalized to 34,000 per sample. Alpha and beta diversity were analyzed to assess changes of the overall gut microbiota structure. Alpha diversity describes the overall gut microbiota structure within a single sample.
Insulin Level
early phase (0-30min)
1660 µIU*min/ml
Standard Deviation 716
Insulin Level
late phase response (60-180min)
6361 µIU*min/ml
Standard Deviation 3978

SECONDARY outcome

Timeframe: Week 4

Population: Looking at iAUC for early and late response phase after meal.

Insulin levels were measured in patients after fiber intervention. Early response to meal post-intervention is 0-30min. Late response phase to meal post-intervention is 60-180min.

Outcome measures

Outcome measures
Measure
Microbiome Structure
n=10 Participants
In this pilot study, we collected 20 fecal samples from 10 subjects before and after the dietary intervention. We extracted the metagenomic DNA from the fecal samples and applied 16S rRNA gene amplicon sequencing to understand the impact of NBT-NM108 on the gut microbiome. We obtained \~980,000 high-quality sequencing reads from 20 samples and have identified 757 amplicon sequence variants (ASVs) from these samples. For subsequent analysis the number of sequencing reads per sample was normalized to 34,000 per sample. Alpha and beta diversity were analyzed to assess changes of the overall gut microbiota structure. Alpha diversity describes the overall gut microbiota structure within a single sample.
Insulin Level
early phase (0-30min)
1607 µIU*min/ml
Standard Deviation 783
Insulin Level
late phase response (60-180min)
7427 µIU*min/ml
Standard Deviation 3644

SECONDARY outcome

Timeframe: Week 0

Population: Looking at iAUC for early and late response phase after meal.

Glucose levels were measured in patients before fiber intervention. Early phase (0-30min) and late phase response (60-180min) to a mixed meal tolerance test was collected.

Outcome measures

Outcome measures
Measure
Microbiome Structure
n=10 Participants
In this pilot study, we collected 20 fecal samples from 10 subjects before and after the dietary intervention. We extracted the metagenomic DNA from the fecal samples and applied 16S rRNA gene amplicon sequencing to understand the impact of NBT-NM108 on the gut microbiome. We obtained \~980,000 high-quality sequencing reads from 20 samples and have identified 757 amplicon sequence variants (ASVs) from these samples. For subsequent analysis the number of sequencing reads per sample was normalized to 34,000 per sample. Alpha and beta diversity were analyzed to assess changes of the overall gut microbiota structure. Alpha diversity describes the overall gut microbiota structure within a single sample.
Glucose Level
early phase (0-30min)
264 mmol*min/mL
Standard Deviation 288
Glucose Level
late phase response (60-180min)
301 mmol*min/mL
Standard Deviation 503

SECONDARY outcome

Timeframe: Week 4

Population: Glucose levels were measured in patients after fiber intervention. Early phase (0-30min) and late phase response (60-180min) to a mixed meal tolerance test was collected.

Glucose levels were measured in patients after fiber intervention. Early phase (0-30min) and late phase response (60-180min) to a mixed meal tolerance test was collected.

Outcome measures

Outcome measures
Measure
Microbiome Structure
n=10 Participants
In this pilot study, we collected 20 fecal samples from 10 subjects before and after the dietary intervention. We extracted the metagenomic DNA from the fecal samples and applied 16S rRNA gene amplicon sequencing to understand the impact of NBT-NM108 on the gut microbiome. We obtained \~980,000 high-quality sequencing reads from 20 samples and have identified 757 amplicon sequence variants (ASVs) from these samples. For subsequent analysis the number of sequencing reads per sample was normalized to 34,000 per sample. Alpha and beta diversity were analyzed to assess changes of the overall gut microbiota structure. Alpha diversity describes the overall gut microbiota structure within a single sample.
Glucose Level
early phase (0-30min)
182 mmol/L
Standard Deviation 222
Glucose Level
late phase response (60-180min)
375 mmol/L
Standard Deviation 552

SECONDARY outcome

Timeframe: Week 0

24 hour dietary recall recorded in MyFitnessPal application measured in kcal.

Outcome measures

Outcome measures
Measure
Microbiome Structure
n=12 Participants
In this pilot study, we collected 20 fecal samples from 10 subjects before and after the dietary intervention. We extracted the metagenomic DNA from the fecal samples and applied 16S rRNA gene amplicon sequencing to understand the impact of NBT-NM108 on the gut microbiome. We obtained \~980,000 high-quality sequencing reads from 20 samples and have identified 757 amplicon sequence variants (ASVs) from these samples. For subsequent analysis the number of sequencing reads per sample was normalized to 34,000 per sample. Alpha and beta diversity were analyzed to assess changes of the overall gut microbiota structure. Alpha diversity describes the overall gut microbiota structure within a single sample.
Calorie Count
1638 Kcal
Standard Deviation 493

SECONDARY outcome

Timeframe: Week 4

24 hour dietary recall recorded in MyFitnessPal application measured in kcal.

Outcome measures

Outcome measures
Measure
Microbiome Structure
n=10 Participants
In this pilot study, we collected 20 fecal samples from 10 subjects before and after the dietary intervention. We extracted the metagenomic DNA from the fecal samples and applied 16S rRNA gene amplicon sequencing to understand the impact of NBT-NM108 on the gut microbiome. We obtained \~980,000 high-quality sequencing reads from 20 samples and have identified 757 amplicon sequence variants (ASVs) from these samples. For subsequent analysis the number of sequencing reads per sample was normalized to 34,000 per sample. Alpha and beta diversity were analyzed to assess changes of the overall gut microbiota structure. Alpha diversity describes the overall gut microbiota structure within a single sample.
Calorie Count
1840 Kcal
Standard Deviation 564

SECONDARY outcome

Timeframe: Week 0

Population: The questionnaire includes 11 questions measured on a 5-point Likert scale, which are summarized in a total hyperphagia score (range: 11-55). Three subscores were summed: hyperphagic behavior (range: 5-25), hyperphagic drive (range: 4-20) and hyperphagic severity (range: 2-10). The scores should improve from week 0 to week 4 with intervention. Higher scores indicate worse hyperphagia. Our scores reported below are mean +/- standard deviation and not ranges.

Appetite behavior measured by questionnaire measured by likert scale. The scores should improve from week 0 to week 4. Higher scores indicate worse hyperphagia.

Outcome measures

Outcome measures
Measure
Microbiome Structure
n=12 Participants
In this pilot study, we collected 20 fecal samples from 10 subjects before and after the dietary intervention. We extracted the metagenomic DNA from the fecal samples and applied 16S rRNA gene amplicon sequencing to understand the impact of NBT-NM108 on the gut microbiome. We obtained \~980,000 high-quality sequencing reads from 20 samples and have identified 757 amplicon sequence variants (ASVs) from these samples. For subsequent analysis the number of sequencing reads per sample was normalized to 34,000 per sample. Alpha and beta diversity were analyzed to assess changes of the overall gut microbiota structure. Alpha diversity describes the overall gut microbiota structure within a single sample.
Hyperphagia Questionnaire
Hyperphagia behavior
6.18 scores on a scale
Standard Deviation 1.83
Hyperphagia Questionnaire
Hyperphagia drive
6.54 scores on a scale
Standard Deviation 2.20
Hyperphagia Questionnaire
Hyperphagia severity
3.63 scores on a scale
Standard Deviation 1.69

SECONDARY outcome

Timeframe: Week 4

Population: The questionnaire includes 11 questions measured on a 5-point Likert scale, which are summarized in a total hyperphagia score (range: 11-55). Three subscores were summed: hyperphagic behavior (range: 5-25), hyperphagic drive (range: 4-20) and hyperphagic severity (range: 2-10). The scores should improve from week 0 to week 4 with intervention. Higher scores indicate worse hyperphagia. Our scores reported below are mean +/- standard deviation and not ranges.

Appetite behavior measured by questionnaire measured by likert scale. The scores should improve from week 0 to week 4. Higher scores indicate worse hyperphagia. The questionnaire includes 11 questions measured on a 5-point Likert scale, which are summarized in a total hyperphagia score (range: 11-55). Three subscores were summed: hyperphagic behavior (range: 5-25), hyperphagic drive (range: 4-20) and hyperphagic severity (range: 2-10). The scores should improve from week 0 to week 4 with intervention. Higher scores indicate worse hyperphagia.

Outcome measures

Outcome measures
Measure
Microbiome Structure
n=10 Participants
In this pilot study, we collected 20 fecal samples from 10 subjects before and after the dietary intervention. We extracted the metagenomic DNA from the fecal samples and applied 16S rRNA gene amplicon sequencing to understand the impact of NBT-NM108 on the gut microbiome. We obtained \~980,000 high-quality sequencing reads from 20 samples and have identified 757 amplicon sequence variants (ASVs) from these samples. For subsequent analysis the number of sequencing reads per sample was normalized to 34,000 per sample. Alpha and beta diversity were analyzed to assess changes of the overall gut microbiota structure. Alpha diversity describes the overall gut microbiota structure within a single sample.
Hyperphagia Questionnaire
Hyperphagia behavior
5.3 scores on a scale
Standard Deviation 1.7
Hyperphagia Questionnaire
Hyperphagia drive
5.7 scores on a scale
Standard Deviation 1.7
Hyperphagia Questionnaire
Hyperphagia severity
3.1 scores on a scale
Standard Deviation 1.4

Adverse Events

Fiber Intervention

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Keerthana Kesavarapu

Robert Wood Johnson

Phone: 6784690425

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place